Key Points
Introduction
Gata2 is one of the 'heptad' transcription factors that acts on regulatory regions of hematopoietic genes 1 . It is upregulated in vivo in Ly6aGFP + cells undergoing endothelial-tohematopoietic cell transition (EHT), a process by which definitive hematopoietic progenitors (HPC) and HSCs are generated in the embryo 2, 3 . As one of the major regulators of HPC and HSC generation, germline deficiency of Gata2 results in embryonic lethality between E10-E10. 5 and an anemic phenotype, with a decreased number of primitive and definitive HPCs in the yolk sac (YS) and in Gata2 -/-ES cell hematopoietic differentiation cultures [4] [5] [6] . Chimeric embryo generation with Gata2 -/-ES cells revealed defective production of all hematopoietic lineages 5 . The E10.5 lethality of Gata2 -/embryos precludes the study of HSC generation in the aorta-gonad-mesonephros (AGM) region, the first site of de novo HSC production.
Gata2 +/embryos contain greatly reduced number of HSCs in the AGM region 7, 8 . Gata2 haploinsufficiency perturbs adult HSC homeostasis in mouse 9 , and in man leads to MonoMac syndrome 10 , which is associated with sporadic myelodysplasia and myeloid leukemia. Also, rearrangement of the remote Gata2 enhancer drives acute myeloid leukemogenesis by activating Evi1 expression 11, 12 . Overexpression studies also reveal that levels of Gata2 expression are important for its hematopoietic function [13] [14] [15] . In situ hybridization studies localize Gata2 expression to aortic endothelial cells, intraaortic hematopoietic cluster cells, placenta (PL) and fetal liver (FL) in the midgestation mouse [16] [17] [18] . Conditional knockout of Gata2 or Gata2 regulatory elements in vascular endothelial cells indicates that Gata2 is essential for hematopoietic cluster formation and HSC generation 7, 19, 20 . Gata2 plays a role in the emergence of cKit-expressing hematopoietic cells from the endothelium 7 . Later, as shown in VavCre conditional knockout mice, Gata2 is essential for HSC maintenance 7 , thus demonstrating a role for Gata2 as previously recognized in bone marrow LSK HSCs 21 .
To date, the correlation between Gata2 and hematopoietic cell generation in the embryo has been made in the absence of prospective isolation of viable Gata2-expressing cells 16 . Although some hematopoietic cells remain in the embryo in the absence of Gata2 5-8 , the identity of these cells is unknown. In this study, to further understand the requirement for Gata2 in normal hematopoietic development, we create and use a mouse model in which a fluorescent reporter for Gata2 (IRES-Venus knock-in gene) does not affect the normal level or function of Gata2. We demonstrate that all long-term repopulating HSCs and a large percentage of HPCs in the midgestation mouse embryo are Venus-positive. We isolate and characterize a Venus-negative HPC population that corresponds to the HPCs found in Gata2-null embryos. Gata2-independent hematopoietic progenitors are functionally less complex and do not follow the same genetic program as Gata2-dependent HPCs.
Materials and methods

Results
Generation and validation of a novel Gata2 reporter mouse model
Previously, analysis of Gata2-expressing cells has been limited to a reporter mouse model that results in Gata2 haploinsufficiency 16 . Our approach allows for the expression of the reporter within the Gata2 genomic locus without affecting the levels of Gata2 expression or protein function. This is particularly important since Gata2 haploinsufficiency greatly reduces the number of HS/PCs generated during development 7, 8, 19, 20, 28 . Briefly, an internal ribosome entry site sequence (IRES) followed by the Venus fluorochrome gene was recombined into the Gata2 3'UTR (Fig1A) in embryonic stem cells (ESC). The resulting Gata2Venus (G2V) mice bred normally and showed no overt growth or hematopoietic defects.
To determine whether Venus reporter expression parallels that of Gata2, G2V bone marrow (BM) cells were sorted into Venus-expressing (Venus + ) and non-expressing (Venus -) Whole mount images of E10 and E11 G2V embryos immunostained with anti-CD31 antibody (marks all endothelial cells and hematopoietic cluster cells) shows Venus + cells along the aorta (DA). Venus + cells are also observed in cells of the neural tube (NT), olfactory bulb (OB) and FL (Fig2A-C). In the E10.5 AGM region (DAPI-and CD31-stained (blue and red respectively)), Venus expression is found in endothelial and hematopoietic cluster cells mainly on the ventral side of the DA and in the urogenital (UG) region (Fig2D,E).
In the FL, Venus-expressing cells are found in a punctate distribution pattern (Fig2D,F Venus expression is similar to what has been previously documented for Gata2 in situ hybridization analysis 29, 30 . Thus, our model allows for the prospective identification, isolation and characterization of Gata2-expressing cells during normal development.
All HSCs, but not all HPCs, express Gata2
To test for HSC activity, E11 AGM Venus + and Venuscells were transplanted into irradiated adult recipients. All long-term repopulating HSCs were found in the Gata2Venusexpressing fraction (Fig3A). 9 of 19 recipients receiving Venus + cells were engrafted (15-71%), whereas none of 14 Venusrecipients showed donor-derived hematopoietic cells. 
Some HPCs and vascular cluster cells are formed in the absence of Gata2
Since the Venusfractions of midgestation G2V hematopoietic tissues contain CFU-C, we tested whether such hematopoietic progenitors are present in Gata2-deleted embryos.
CFU-Cs were detected in the Gata2 -/-E9 AGM, E10 AGM (Fig4A) and E10 VA+UA (Fig4B), although significantly fewer as compared to WT (Table3). Gata2 +/tissues also contained fewer CFU-Cs compared to WT. The E9 Gata2 -/-YS contained the most CFU-C (64.4±12.2)(Fig4C). In VEC-Cre:Gata f/f embryos, E10 PL showed significantly decreased CFU-C numbers (Fig4D), as did E10 AGM and YS 7 when compared to WT. The CFU-C remaining in Gata2 -/embryos are predominantly CFU-G and CFU-M. Very few Gata2 -/-CFU-GM and no CFU-GEMM were observed. These data support and validate our findings in G2V embryos that not all HPCs are Gata2-expressing, Gata2-independent progenitors exist in each of the early hematopoietic tissues, and the Gata2-expressing cell fraction is more enriched in multipotent progenitors.
Since hematopoietic clusters appear in the VA and UA prior to appearance in the aorta, and are larger than in the AGM 31 , we further examined these vessels. Whole-mount microscopic analysis demonstrates that clusters form in the absence of Gata2. The number and size of cKit + hematopoietic clusters in early E10 Gata2 +/and Gata2 -/-VA+UA are decreased as compared to WT(Fig4E). The number of cKit + cells decreases 20-fold in the
suggesting that these emerging cKit + hematopoietic cluster cells are part of the cohort of Gata2-independent HPCs.
An alternative genetic program is expressed in Venushematopoietic cells
The molecular basis for the functional differences observed in Gata2-dependent andindependent HPCs was examined by RNAsequencing. As most CD31 + Venus -HPCs showed ckit intermediate (int) expression, we compared this population to CD31 + Venus + ckit int HPCs (Fig5A). Gene set enrichment analysis (GSEA) on genes sorted by log ratio of Venus + versus Venus -FPKMs revealed that genes in the Ras signalling pathway were significantly enriched in the Venus + as compared to the Venusfraction (Fig5B). Genes upregulated by Ras were enriched in the Venus + fraction, and highly upregulated genes included Kras, Grb2 (Ras adaptor), and Sos1 and Sos2 (RasGEF activators) (Fig5C). Genes downregulated by Ras were enriched in the Venusfraction. RasGAP gene (render Ras inactive) Rasa2 was highlyupregulated in the Venusfraction, whereas Rasa1 and Rasa3 were highly-upregulated in the Venus + fraction. Rasa4 and NF1 were expressed to similar levels. Also, Venus + HPCs show increased levels of CREB and CBP expression as compared to Venus -HPCs, and express PKA catalytic subunit genes, suggesting that Venus + HPCs have the potential to activate CREB target genes. Gata2 has CREB Response Element consensus sites (-3kb,-300bp upstream tss) suggesting that it is a downstream target 32, 33 . As Gata2 is a Notch target 18 , a 2-4-fold higher expression of Notch1 and Notch4 was found in the Venus + fraction (Fig5D).
Moreover, Snw1 and Maml1 (transcriptional co-activators in the Notch pathway that interact with Notch) were upregulated (2-and 30-fold respectively) in Gata2-expressing HPCs.
Since Venus -HPCs are mainly restricted in their differentiation potential to the macrophage and granulocytic lineages, we evaluated their similarity to YS-derived erythromyeloid progenitors (EMPs) that give rise to tissue-resident macrophages. Flow cytometric analysis for EMP markers 34 expression was also found in aortic endothelial (CD34 + ) cells, but it did not overlap with Gata2 expression(Fig6D). Together, these results suggest that Gata3 and/or Gata4 may provide some function in Gata2-independent hematopoietic cells.
Discussion
In this study we prospectively enriched and characterized Gata2-dependent andindependent HPC subsets from our novel Gata2Venus reporter mouse. Molecular analyses, together with the fact that some vascular hematopoietic cluster cells and HPCs persist in the absence of Gata2 expression suggest that an alternative genetic program exists for the production of HPCs. The transcriptome differences observed between Venus + and Venus -HPCs may offer possibilities for pathway modifications to achieve the programming complexities necessary for the generation/function of normal definitive HPCs and provide insights into the factors involved in myeloid leukemogenesis.
Gata2 expression in the developing hematopoietic system
We showed the temporal and quantitatively coordinate transcription of Venus and Gata2 in our G2V mouse model. The strategy used 37 eliminates expression level and protein alterations that affect HP/SC development. In G2V embryos, we showed that the cells with the most robust and complex hematopoietic potential (all HSCs and most HPCs) are Gata2expressing. Imaging and FACS analyses of G2V embryos confirm that Gata2 is expressed in all hematopoietic sites during midgestation and that the numbers of Gata2-expressing cells reflect the developmental and temporal hematopoietic changes occurring in each site. At E9 Gata2-expressing cells are found predominantly in the YS, which at this time produces the highest numbers of the hematopoietic progenitors (EMP) in the conceptus. Slightly later as hematopoiesis begins in the AGM and FL, the numbers of Gata2-expressing cells also increase. The highest numbers of CD31 + cKit + cluster cells are found in the aorta, VA and UA at E10.5, as quantitated by whole mount embryo imaging 31 . Most, but not all hematopoietic cluster cells express Gata2, and Gata2 expression may be downregulated as HPCs differentiate. However, we found some hematopoietic cluster cells and HPCs in the E10 Gata2 -/vasculature, confirming the existence of Gata2-independent HPCs 5 .
Importantly, Gata2 is expressed in the endothelial cells of the DA. Already at E8.5, endothelial cells lining the paired dorsal aortae express Gata2 and it continues to be expressed in the E10.5 aorta when HSCs are generated, thus highlighting an involvement of Gata2 in the hemogenic program of endothelial cells. Data in VE-cadherin conditional Gata2deficient mice and other models 7, 19, 28, 38 strongly support the notion that Gata2 is required in hemogenic endothelium for the emergence of HSCs, as does the morpholino knockdown of Gata2b in Zebrafish 39 .
Gata2 and the relationship with hematopoietic function
Prospective isolation and in vivo transplantation showed that all HSCs are Gata2expressing. In contrast, some HPCs are present in the Venuscell fractions of G2V hematopoietic tissues and Gata2 -/hematopoietic tissues. In both cases, the HPCs are restricted in their differentiation potential to predominantly the macrophage and granulocytic lineages. Currently, the EMP population is of high interest as a novel hematopoietic cell subset providing tissue resident macrophages 35, [40] [41] [42] . Our FACS data revealed that EMPs are mainly in the Venuscell population of E10 YS and AGM, and increased in the Venus + population at E11. Chemokine receptor/ligand gene sets obtained from a study on EMP/microglia transcriptome comparisons allowed us to find similarities in chemokine receptor/ligand expression between EMPs and the Venus -HPC fraction.
Despite prevalence of EMPs in the Venuscell population in E10 YS and AGM, definitive progenitors are largely Venus + . The co-existence of these HPC subsets highlight the fact that there is more diversity in the types of progenitors generated in the embryo than was previously appreciated. In support of this is recent data from ESC hematopoietic differentiation cultures suggesting that there are two different hemogenic endothelial cell subsets 43 and the fact that in vivo, the AGM, VA/UA, YS, PL and head are all hemogenic tissues 34, 44, 45, 46, 47 .
The highest number of Venus -HPCs were found in E9 and E10 YS (270.0±69.8 and 130.0±25.5 CFU-C, respectively) as compared to other tissues (PL, AGM, VA+UA). It is clear that Gata2 has an important role in EHT in the hemogenic endothelial cell compartment before or during the generation/emergence of hematopoietic cells, as evidenced by the decrease (but not absence) in the hematopoietic cluster cells in Gata2 -/aorta, VA and UA.
However, it is as yet unclear at what frequency EHT occurs in the YS, thus raising the possibility that Gata2-independent HPCs arise differently than Gata2-dependent HPCs (perhaps directly from hemangioblasts 48 ).
We found differences in the number of CFU from E9 YS Venuscells (270.0±69) and
Gata2 -/cells (64.4±12.2) (Fig4C,3D, Tables 2,3 ). The 4-fold lower CFU number is likely related to observations (ours and others) that colonies from Gata2 -/embryos, YS explants and ESC differentiations were smaller/less proliferative than WT colonies, due to the complete absence of Gata2 6, 7 . Venuscells are not defective for Gata2 and resulting colonies are normal in size. Whereas at the time of sorting they did not express Gata2, Gata2 expression could initiate after seeding Venus -HPCs in methylcellulose and cells thus undergo normal proliferation/differentiation. To test whether Venus -HPCs can convert to Venus + cells, we analysed Venus expression in colonies derived from sorted YS fractions after 10 days of differentiation (Fig7). Venus expression was found in colonies derived from both fractions, indicating that a portion of Venuscells start to express Gata2 during formation of a hematopoietic colony. Interestingly, colonies derived from Venus + cells showed a Gr1 + and Mac1 + phenotype, whereas Venus --derived colony cells were only Mac1 + . This demonstrates that Gata2 is not necessary for a subset of HPCs and that Gata2 promotes more complex hematopoietic function in other progenitor subsets.
Gata3/Gata4 redundancy in Gata2 independent progenitors
The expression of Gata3 and Gata4 in Venus -AGM HPCs and aortic endothelial cells is intriguing and highlights the potential redundancy of Gata transcription factors in hematopoietic cell generation. Gata2 and Gata3 can partially rescue the erythroid phenotype in Gata1 deficient mice 49, 50 and while recently it was suggested that Gata3 is redundant in HSCs 51 , others clearly show that it regulates HSC cell-cycle entry 52 and self-renewal 53 . The fact that Gata3 and Gata4 are expressed in Gata2-non-expressing enriched HPCs suggests that they may function in this early progenitor subset. Gata3-deficient embryos show decreased numbers of FL HP/SCs 54 . Gata3 affects HSC development non-cell autonomously by activating the expression of Th (tyrosine hydroxylase) and hence, catecholamine production in the ventro-lateral cells of the sympathetic nervous system underlying the embryonic aorta 36 . HSC production was rescued when catecholamines were administered to the pregnant dams. These investigators also found that some aortic endothelial cells express a Gata3LacZ reporter, leaving open the possibility of a direct and overlapping role for Gata3 in some HPCs.
Much less is known concerning Gata4 in hematopoietic development. In Zebrafish there is a close relationship between anterior hemangioblasts and cardiac precursors 55 .
Together with Gata5 and Gata6, Gata4 specifies these two anterior mesoderm derivatives. In mouse, Gata4 is a key component of the cardiac developmental program, with close associations between cardiac, vascular and hematopoietic lineages [56] [57] [58] The low expression of Notch1, Notch4 and co-activators in the Venusas compared to the Venus + HPC fraction, supports the fact that early hematopoietic cells are generated independent of this signaling pathway, or implies that these are differentiated cells which have turned off Notch signalling 65 . Others have shown that Notch1 deletion impairs the development of HSCs and angiogenesis 66 , but not YS primitive or definitive hematopoiesis.
Moreover, Gata2 expression in the aortic endothelium is lost when Jagged1 (ligand) is deleted 67 . Our data demonstrate a direct relationship for Notch and Gata2 expression, strongly supporting a pivotal role for this pathway in the generation of functionally-complex hematopoietic cells. In the absence of Notch signaling, less complex HPC emerge in the AGM or are immigrants from the YS 18, 66, 67 . In addition, our observed upregulated-expression of some CREB genes in Venus + HPCs supports the involvement of these regulators in definitive hematopoietic cell generation 68 . Our Gata2Venus model, in combination with recently reported Gata2 distal enhancer-Evi1 mouse model, will allow for a direct examination of the cells relevant to leukemogenesis 12 .
In conclusion, we have enriched, localized and characterized Gata2-dependent and independent subsets of hematopoietic progenitors in Gata2Venus embryos. The combination of this reporter with other reporter and KO models will lead to a better understanding of the role of Gata2 (and other factors) in the development and function of multipotential HP/SCs in health, leukemogenesis and reprogramming. Table 1 ). 
